Two signatures of RNA-binding proteins enrolled the CTU1 gene as a vital indicator to predict the survival of prostate cancer and bladder urothelial carcinoma (Guo et al., 2020; Hua et al., 2020). This evidence concerns the gene CTU1 and prostate cancer.